Cambridge Investment Research Advisors, Inc. - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 168 filers reported holding FIBROGEN INC in Q4 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of FIBROGEN INC
ValueSharesWeighting
Q1 2022$128,000
-14.7%
10,6310.0%0.00%0.0%
Q4 2021$150,000
+35.1%
10,631
-1.8%
0.00%0.0%
Q3 2021$111,000
-46.6%
10,831
+80.5%
0.00%0.0%
Q1 2021$208,000
-34.0%
6,000
-29.4%
0.00%
-50.0%
Q4 2020$315,000
-27.1%
8,500
-19.1%
0.00%
-33.3%
Q3 2020$432,000
-7.1%
10,509
-8.5%
0.00%0.0%
Q2 2020$465,000
+18.0%
11,484
+1.2%
0.00%
-25.0%
Q1 2020$394,000
-19.8%
11,350
-0.8%
0.00%0.0%
Q4 2019$491,000
+19.2%
11,438
+2.6%
0.00%0.0%
Q3 2019$412,000
-18.3%
11,1500.0%0.00%
-20.0%
Q2 2019$504,00011,1500.01%
Other shareholders
FIBROGEN INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders